IN VITRO INITIATION OF BIOLOGICAL CALCIFICATION
生物钙化的体外引发
基本信息
- 批准号:3158275
- 负责人:
- 金额:$ 13.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-08-01 至 1992-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cartilage calcification is an essential step in the processes of
fracture healing and bone growth (endochondral ossification).
The goal of the proposed studies is to determine the ways in
which cartilage calcification is regulated. Since mammals and
birds demonstrate different patterns of cartilage calcification
they provide excellent models for examining these regulatory
process. Mammalian and avian cartilage calcification can be
differentially modeled in vitro using a well developed model of
chondrogenesis. Chondrogenesis (cartilage formation) occurs in
vitro when mesenchymal cells (isolated from embryonic limb
buds) are cultured at high density in media containing 1 mM
calcium: the matrix will calcify in the presence of 3-4 mM
inorganic phosphate. The long range goal of the proposed study
is to use chick and mouse mesenchymal cell systems to
characterize events in initial calcification. Chemical analyses,
light and electron microscopy, x-ray diffraction and infra-red
spectroscopy, and immunochemistry will be used to evaluate the
mineralized matrix formed in vitro. Experiments are designed
initially to optimize the culture conditions to provide maximal
"physiologic" matrix mineralization by varying a) ascorbic acid,
b) phosphate, c) beta-glycerol phosphate, d) calcium, e) fetal calf
serum, and f) atmospheric conditions. The calcified tissue
formed in the avian and murine cell culture systems will be
compared to each other and to mineralized cartilage produced in
vivo, with respect to: a) type of matrix undergoing
mineralization, b) mineral characteristics, and c) cells regulating
the mineralization process. The cultured cells will than be
chemically or physically modified in order to test the hypothesis
that viable, as opposed to necrotic, cells are responsible for
mineralization. The effect of alteration of matrix properties on
mineralization will be examined by using agents that alter: a)
cartilage differentiation and development (BrDU and vitamin A),
b) proteoglycan synthesis, composition and/or properties (vitamin
A, xylosides, hyaluronidase, polylysine), and c) synthesis of other
extracellular matrix proteins (cAMP). The culture systems will
be examined to determine how clinically relevant trace elements
(F, A1, Fe, Ga, Ti, V, Ni, Cr and Co) control the extent of cell
mediated mineralization. These cell culture studies are unique
due to their emphases on the mechanism of cell-mediated
calcification. Their clinical significance comes from the basic
information on calcification mechanisms they will provide as
well as from the specific data they will generate on the effect of
certain therapies on these mechanisms.
软骨钙化是一个重要的步骤,
骨折愈合和骨生长(软骨内骨化)。
拟议研究的目标是确定
软骨钙化是受调节的。 由于哺乳动物和
鸟类表现出不同的软骨钙化模式
他们提供了很好的模型来检查这些监管
过程 哺乳动物和鸟类的软骨钙化可以
在体外使用良好开发的模型进行差异建模,
软骨形成 软骨发生(软骨形成)发生在
当间充质细胞(从胚胎肢体分离)时,
芽)在含有1 mM
钙:基质在3-4 mM钙存在下钙化
无机磷酸盐 拟议研究的长期目标
是用鸡和老鼠的间充质细胞系统
表征初始钙化中的事件。 化学分析,
光学和电子显微镜、x射线衍射和红外线
光谱学和免疫化学将用于评估
体外形成矿化基质。 实验设计
最初优化培养条件以提供最大的
通过改变a)抗坏血酸,
B)磷酸盐,c)β-甘油磷酸盐,d)钙,e)胎牛
血清和f)大气条件。 钙化组织
在禽类和鼠类细胞培养系统中形成的细胞将
与其他组织相比,
体内,关于:a)经历的基质类型
矿化,B)矿物质特征,以及c)细胞调节
矿化过程。 培养的细胞将比
化学或物理改性,以检验假设
与坏死细胞相反,
成矿 基质性质改变对
矿化将通过使用改变以下的试剂来检查:a)
软骨分化和发育(BrDU和维生素A),
B)蛋白聚糖的合成、组成和/或性质(维生素
A,木糖苷,透明质酸酶,聚赖氨酸),和c)其他的合成
细胞外基质蛋白(cAMP)。 文化体系将
以确定临床相关的微量元素
(F、Al、Fe、Ga、Ti、V、Ni、Cr和Co)控制晶胞的大小
介导的矿化。 这些细胞培养研究是独一无二的
由于他们强调细胞介导的机制,
钙化 它们的临床意义来自于
他们将提供钙化机制的信息,
以及从他们将产生的影响的具体数据,
这些机制上的某些疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADELE L BOSKEY其他文献
ADELE L BOSKEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADELE L BOSKEY', 18)}}的其他基金
Noncollagenous Protein Interaction in Biomineralization
生物矿化中的非胶原蛋白相互作用
- 批准号:
8317807 - 财政年份:2012
- 资助金额:
$ 13.43万 - 项目类别:
Noncollagenous Protein Interaction in Biomineralization
生物矿化中的非胶原蛋白相互作用
- 批准号:
8450737 - 财政年份:2012
- 资助金额:
$ 13.43万 - 项目类别:
FT-IR MICROSCOPY OF MINERAL STRUCTURE IN OSTEOPOROSIS
骨质疏松症矿物结构的 FT-IR 显微镜
- 批准号:
7847299 - 财政年份:2009
- 资助金额:
$ 13.43万 - 项目类别:
Micro-computed tomography system (Micro-CT)
微型计算机断层扫描系统(Micro-CT)
- 批准号:
7385174 - 财政年份:2008
- 资助金额:
$ 13.43万 - 项目类别:
OSTEOPOROSIS, COLLAGEN CROSS-LINKS & BIOMECHANICS
骨质疏松症、胶原蛋白交联
- 批准号:
6651108 - 财政年份:2001
- 资助金额:
$ 13.43万 - 项目类别:
相似海外基金
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis
对乙酰氨基酚和抗坏血酸脓毒症试验中器官功能障碍和恢复的机制
- 批准号:
10502613 - 财政年份:2022
- 资助金额:
$ 13.43万 - 项目类别:
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis
对乙酰氨基酚和抗坏血酸脓毒症试验中器官功能障碍和恢复的机制
- 批准号:
10644023 - 财政年份:2022
- 资助金额:
$ 13.43万 - 项目类别:
Ascorbate and glutathione integrate the control of grapevine development
抗坏血酸和谷胱甘肽整合控制葡萄树的发育
- 批准号:
DP210102178 - 财政年份:2022
- 资助金额:
$ 13.43万 - 项目类别:
Discovery Projects
Finessing, Extending and Developing an Overview of the Regulation of Ascorbate in plants (FEDORA)
精炼、扩展和发展植物中抗坏血酸的调控概述 (FEDORA)
- 批准号:
BB/W006553/1 - 财政年份:2022
- 资助金额:
$ 13.43万 - 项目类别:
Research Grant
Finessing, Extending and Developing an Overview of the Regulation of Ascorbate in plants (FEDORA)
精炼、扩展和发展植物中抗坏血酸的调控概述 (FEDORA)
- 批准号:
BB/W006707/1 - 财政年份:2022
- 资助金额:
$ 13.43万 - 项目类别:
Research Grant
The role of ascorbate in myelopoiesis and infection
抗坏血酸在骨髓生成和感染中的作用
- 批准号:
10582571 - 财政年份:2021
- 资助金额:
$ 13.43万 - 项目类别:
The role of ascorbate in myelopoiesis and infection
抗坏血酸在骨髓生成和感染中的作用
- 批准号:
10210088 - 财政年份:2021
- 资助金额:
$ 13.43万 - 项目类别:
The role of ascorbate in myelopoiesis and infection
抗坏血酸在骨髓生成和感染中的作用
- 批准号:
10374915 - 财政年份:2021
- 资助金额:
$ 13.43万 - 项目类别:
Regulation of light-dependent synthesis of L-ascorbate in plants
植物中 L-抗坏血酸光依赖性合成的调控
- 批准号:
19K06702 - 财政年份:2019
- 资助金额:
$ 13.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Reversing age-related reductions in heat loss responses via the administration of ascorbate
通过服用抗坏血酸逆转与年龄相关的热损失反应减少
- 批准号:
525181-2018 - 财政年份:2018
- 资助金额:
$ 13.43万 - 项目类别:
University Undergraduate Student Research Awards














{{item.name}}会员




